Aquatic Capital Management’s Myriad Genetics MYGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-82,579	Closed	-$508K	–	1666
2025 Q4	$508K	Buy	82,579 +31,699	+62%	+$230K	0.01%	728
2025 Q3	$368K	Buy	50,880 +27,593	+118%	+$164K	0.01%	950
2025 Q2	$124K	Sell	23,287 -9,464	-29%	-$55.9K	﹤0.01%	1069
2025 Q1	$291K	Buy	32,751 +7,823	+31%	+$94K	0.01%	867
2024 Q4	$342K	Buy	24,928 +13,328	+115%	+$246K	0.01%	815
2024 Q3	$318K	Buy	11,600 +1,900	+20%	+$51.4K	0.01%	735
2024 Q2	$237K	Buy	9,700 +4,800	+98%	+$105K	0.01%	715
2024 Q1	$104K	Buy	+4,900	New	+$105K	﹤0.01%	902
2023 Q4	–	Sell	-5,200	Closed	-$83K	–	1526
2023 Q3	$83K	Buy	+5,200	New	+$99K	﹤0.01%	853
2023 Q2	–	Sell	-16,100	Closed	-$374K	–	1610
2023 Q1	$374K	Sell	16,100 -7,800	-33%	-$158K	0.02%	469
2022 Q4	$346K	Buy	23,900 +16,700	+232%	+$311K	0.03%	596
2022 Q3	$137K	Buy	+7,200	New	+$165K	0.01%	687